These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7092577)

  • 1. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias.
    Beaumont JL; Jacotot B; Buxtorf JC; Silvestre M; Beaumont V
    Artery; 1982; 10(1):71-87. PubMed ID: 7092577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of probucol on skin cholesterol concentrations in patients with type II hyperlipoproteineamia (author's transl)].
    Beaumont JL; Jacotot B; Buxtorf JC; Meliço-Silvestre AA; Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):2995-3000. PubMed ID: 7443438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of free and esterified cholesterol in skin in atherogenic hyperlipidemias.
    Melico-Silvestre AA; Jacotot B; Buxtorf JC; Beaumont V; Beaumont JL
    Pathol Biol (Paris); 1981 Nov; 29(9):573-8. PubMed ID: 7033903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative effects of probucol and placebo on blood cholesterol in patients on long-term treatment (author's transl)].
    Mc Caughan D
    Nouv Presse Med; 1980 Oct; 9(40):3018-20. PubMed ID: 7443444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Free and esterified cholesterol of the skin in atherogenic hyperlipidemias].
    Melico-Sylvestre AA; Jacotot B; Buxtorf JC; Beaumont V; Beaumont JL
    Paroi Arterielle; 1981; 7(2):59-65. PubMed ID: 7322621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia.
    LeLorier J; DuBreuil-Quidoz S; Lussier-Cacan S; Huang YS; Davignon J
    Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of probucol in man (author's transl)].
    Leutenegger M
    Nouv Presse Med; 1980 Oct; 9(40):2985-9. PubMed ID: 7443436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of several lipid-lowering drugs on skin total and esterified cholesterol.
    Jacotot B; Beaumont JL; Beaumont V; Buxtorf JC; Edouard L; Doucet F; Carcone B
    Monogr Atheroscler; 1986; 14():193-7. PubMed ID: 3526124
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
    Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
    Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prolonged probucol treatment in patients with cardiovascular diseases (author's transl)].
    Scebat L; Renais J
    Nouv Presse Med; 1980 Oct; 9(40):3008-10. PubMed ID: 7443441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of homozygous familial hypercholesterolaemia with probucol.
    Baker SG; Joffe BI; Mendelsohn D; Seftel HC
    S Afr Med J; 1982 Jul; 62(1):7-11. PubMed ID: 7089781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of probucol on bile composition in man.
    Jirsa M; Marecek Z; Kerdac V; Kucerova L
    Artery; 1982; 10(1):44-7. PubMed ID: 7092575
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias].
    Goranov I; Naumova R; Kerekovska M; Balabanski L
    Vutr Boles; 1987; 26(1):96-101. PubMed ID: 3590738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia].
    Kawecka-Jaszcz K; Kocemba J; Wasowicz B; Król W
    Kardiol Pol; 1982; 25(5-6):377-82. PubMed ID: 6759746
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of probucol on homozygous cases of familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Kishino B; Hayashi R; Hirobe K; Kikkawa T
    Atherosclerosis; 1983 Aug; 48(2):157-66. PubMed ID: 6615580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].
    Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):3011-3. PubMed ID: 7443442
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-macrophage-related accumulation of cholesterol during probucol treatment in familial hypercholesterolemia: report of two cases.
    Nakamura T; Ueyama Y; Funahashi T; Yamashita S; Takemura KK; Kubo M; Yamada K; Matsuzawa Y
    Atherosclerosis; 1992 Feb; 92(2-3):193-202. PubMed ID: 1632848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.